"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 |
| 1997 | 7 | 0 | 7 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 4 | 8 |
| 2000 | 5 | 1 | 6 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 2 | 6 |
| 2003 | 6 | 6 | 12 |
| 2004 | 22 | 8 | 30 |
| 2005 | 11 | 8 | 19 |
| 2006 | 24 | 6 | 30 |
| 2007 | 31 | 7 | 38 |
| 2008 | 22 | 6 | 28 |
| 2009 | 32 | 11 | 43 |
| 2010 | 21 | 9 | 30 |
| 2011 | 38 | 14 | 52 |
| 2012 | 35 | 24 | 59 |
| 2013 | 43 | 11 | 54 |
| 2014 | 54 | 16 | 70 |
| 2015 | 52 | 15 | 67 |
| 2016 | 68 | 13 | 81 |
| 2017 | 43 | 15 | 58 |
| 2018 | 69 | 11 | 80 |
| 2019 | 74 | 13 | 87 |
| 2020 | 86 | 10 | 96 |
| 2021 | 87 | 10 | 97 |
| 2022 | 96 | 1 | 97 |
| 2023 | 95 | 3 | 98 |
| 2024 | 79 | 17 | 96 |
| 2025 | 63 | 13 | 76 |
| 2026 | 14 | 1 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
American Heart Association cardiovascular health metrics and cancer outcomes: A systematic review and meta-analysis. Am Heart J. 2026 Jul; 297:107426.
-
Global Burden of Cardiovascular Disease: What Should Be Expected in the Next 25 Years? Curr Cardiol Rep. 2026 Mar 14; 28(1).
-
Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer. Eur J Prev Cardiol. 2026 Mar 13; 33(4):513-525.
-
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines. J Am Coll Cardiol. 2026 Apr 21; 87(15):1936-1949.
-
Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank. J Am Heart Assoc. 2026 Mar 03; 15(5):e042582.
-
Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2026 Mar 03; 15(5):e043281.
-
Phosphodiesterase 8 regulation of excitation-contraction coupling as a target for cardiovascular disease: is it my turn now? Am J Physiol Heart Circ Physiol. 2026 04 01; 330(4):H1102-H1116.
-
The evolving therapeutic landscape of PCSK9 inhibition. Atherosclerosis. 2026 Mar; 414:120670.
-
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. N Engl J Med. 2026 Feb 05; 394(6):529-539.
-
A Systematic Review and Meta-Analysis of Breast Arterial Calcification and Its Association With Cardiovascular Disease and All-Cause Mortality. Am J Cardiol. 2026 Apr 15; 265:7-16.